LONDON–(BUSINESS WIRE)–Dec 7, 2024–MiNA Therapeutics Limited, the pioneer in small activating RNA (RNAa) therapeutics, today presented new pre-clinical data for its lead RNA activation program for the treatment of sickle cell disease, which demonstrated best-in-class activity and safety. The data shared at the 2024 American…

Finance

Latest News

View More
© 2024 The Business Times. All Rights Reserved.